An Integrated Analysis of the Identified PRPF19 as an Onco-immunological Biomarker Encompassing the Tumor Microenvironment, Disease Progression, and Prognoses in Hepatocellular Carcinoma

Background: Targeting the mRNA splicing process has been identified as a therapeutic strategy for human cancer. PRPF19 is an RNA binding protein that is involved in pre-mRNA processing and repairing DNA damage; the aberrant expression of PRPF19 is potentially associated with carcinogenesis. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ming, Qiu, Yiwen, Yang, Yi, Wang, Wentao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893313/
https://www.ncbi.nlm.nih.gov/pubmed/35252202
http://dx.doi.org/10.3389/fcell.2022.840010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893313/
https://www.ncbi.nlm.nih.gov/pubmed/35252202
http://dx.doi.org/10.3389/fcell.2022.840010

Ejemplares similares